ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ET
31 Julho 2023 - 8:17AM
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP)
today announced that the Company will release its second quarter
2023 financial results on Wednesday, August 9, 2023, prior to the
market open.
Nikhil Lalwani, President and Chief Executive Officer, and
Stephen P. Carey, Senior Vice President, Finance, and Chief
Financial Officer, will host a conference call to discuss the
results as follows:
Date |
Wednesday,
August 9, 2023 |
Time |
8:30 a.m. ET |
Toll free (U.S.) |
800-267-6316 |
Webcast (live and replay) |
www.anipharmaceuticals.com, under the “Investors” section |
A replay of the conference call will be available within two
hours of the call’s completion and will remain accessible for two
weeks by dialing 800-839-2461 and entering access code 119757.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified
biopharmaceutical company serving patients in need by developing,
manufacturing, and marketing high quality branded and generic
prescription pharmaceutical products, including for diseases with
high unmet medical need. Our team is focused on delivering
sustainable growth by scaling up our Rare Disease business through
the successful launch of our lead asset, Purified Cortrophin® Gel,
strengthening our generics business with enhanced development
capability, innovation in established brands and leveraging our
North American manufacturing capabilities. For more information,
please visit our website www.anipharmaceuticals.com.
Investor Relations Contact:Lisa M. Wilson,
In-Site Communications, Inc.212-452-2793lwilson@insitecony.com
SOURCE: ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals (NASDAQ:ANIP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
ANI Pharmaceuticals (NASDAQ:ANIP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024